Seungseok Kang

Seungseok Kang

Auto-generated profile, based on publicly available information

Seungseok Kang

Department of Biomedical Systems Informatics, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul 03722 , Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Nature Methods
Verified
Journal Article
Open access
PDF file
YHYoo-Jin Ha
Yoo-Jin Ha
SKSeungseok Kang
Seungseok Kang
JKJisoo Kim
Jisoo Kim
JKJunhan Kim
Junhan Kim
SJSe-Young Jo
Se-Young Jo
SKSangwoo Kim
Sangwoo Kim
Rapid advances in sequencing and analysis technologies have enabled the accurate detection of diverse forms of genomic variants represented as heterozygous, homozygous and mosaic mutations. However, the best practices for mosaic variant calling remain disorganized owing to the technical and conceptual difficulties faced in evaluation. Here we present our benchmark of 11 feasible mosaic variant detection approaches based on a systematically designed whole-exome-level reference standard that mimics mosaic samples, supported by 354,258 control positive mosaic single-nucleotide variants and insertion-deletion mutations and 33,111,725 control negatives. We identified not only the best practice for mosaic variant detection but also the condition-dependent strengths and weaknesses of the current methods. Furthermore, feature-level evaluation and their combinatorial usage across multiple algorithms direct the way for immediate to prolonged improvements in mosaic variant detection. Our results will guide researchers in selecting suitable calling algorithms and suggest future strategies for developers.

3 February 2022 in Scientific Data
Verified
Journal Article
Open access
PDF file
YHYoo-Jin Ha
Yoo-Jin Ha
MOMyung Joon Oh
Myung Joon Oh
JKJunhan Kim
Junhan Kim
JKJisoo Kim
Jisoo Kim
SKSeungseok Kang
Seungseok Kang
SKSangwoo Kim
Sangwoo Kim
Detection of somatic mosaicism in non-proliferative cells is a new challenge in genome research, however, the accuracy of current detection strategies remains uncertain due to the lack of a ground truth. Herein, we sought to present a set of ultra-deep sequenced WES data based on reference standards generated by cell line mixtures, providing a total of 386,613 mosaic single-nucleotide variants (SNVs) and insertion-deletion mutations (INDELs) with variant allele frequencies (VAFs) ranging from 0.5% to 56%, as well as 35,113,417 non-variant and 19,936 germline variant sites as a negative control. The whole reference standard set mimics the cumulative aspect of mosaic variant acquisition such as in the early developmental stage owing to the progressive mixing of cell lines with established genotypes, ultimately unveiling 741 possible inter-sample relationships with respect to variant sharing and asymmetry in VAFs. We expect that our reference data will be essential for optimizing the current use of mosaic variant detection strategies and for developing algorithms to enable future improvements.

26 June 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YCYoung-Soo Chung
Young-Soo Chung
SKSeungseok Kang
Seungseok Kang
JKJisu Kim
Jisu Kim
SLSangbo Lee
Sangbo Lee
SKSangwoo Kim
Sangwoo Kim
Genome-level clonal decomposition of a single specimen has been widely studied; however, it is mostly limited to cancer research. In this study, we developed a new algorithm CLEMENT, which conducts accurate decomposition and reconstruction of multiple subclones in genome sequencing of non-tumor (normal) samples. CLEMENT employs the Expectation-Maximization (EM) algorithm with optimization strategies specific to non-tumor subclones, including false variant call identification, non-disparate clone fuzzy clustering, and clonal allele fraction confinement. In the simulation and in vitro cell line mixture data, CLEMENT outperformed current cancer decomposition algorithms in estimating the number of clones (root-mean-square-error = 0.58–0.78 versus 1.43–3.34) and in the variant-clone membership agreement (∼85.5% versus 70.1–76.7%). Additional testing on human multi-clonal normal tissue sequencing confirmed the accurate identification of subclones that originated from different cell types. Clone-level analysis, including mutational burden and signatures, provided a new understanding of normal-tissue composition. We expect that CLEMENT will serve as a crucial tool in the currently emerging field of non-tumor genome analysis.